A19_75D30125R73235_Serology Solicitation_Amendment 4.pdf
PDF 304 KB Posted
- Solicitation number
- 75D30125R73235
About this file
This document is Amendment 4 to Solicitation 75D30125R73235 for Serological Assays for the Detection and Characterization of Influenza Viruses, issued by the CDC's Office of Acquisition Services. The amendment suspends the solicitation until further notice and makes several key changes: 1) Vic Veguilla (dhu3@cdc.gov) is added as the new point of contact, replacing Jennifer Gartzke, 2) Evaluation of Phase I will continue as samples are received, but vendors will not be required to submit results for B/Yamagata and B/Victoria positive controls, and 3) progress into Phase II is suspended. The amendment is effective 04/15/2025 and applies to a solicitation originally dated 01/16/2025, with all other terms and conditions remaining unchanged.
View the file
Other files
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
75D30125R7321 1 Page 1 of 1
AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT
1. CONTRACT ID CODE PAGE OF PAGES
1 1
2. AMENDMENT/MODIFICATION NO.
00004
3. EFFECTIVE DATE
04/15/2025
4. REQUISITION/PURCHASE REQ. NO.
000HCJC1-2025-90234
5. PROJECT NO. (If applicable)
6. ISSUED BY CODE 8219 7. ADMINISTERED BY (If other than Item 6) CODE 8219 OFR - Office of Acquisition Services Chamblee Campus Building 102 4770 Buford Highway Atlanta, GA 30341-
OFR - Office of Acquisition Services Chamblee Campus Building 102 4770 Buford Highway Atlanta, GA 30341-
8. NAME AND ADDRESS OF CONTRACTOR (No., street, county, State and ZIP Code)
All Offerors
X
9A. AMENDMENT OF SOLICITATION NO.
75D30125R73235
9B. DATED (See Item 11)
01/16/2025
10A. MODIFICATION OF CONTRACT/ORDER NO.
10B. DATED (See Item 13)
CODE FACILITY CODE
11. THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS
X The above numbered solicitation is amended as set forth in Item 14. The hour and date specified for receipt of Offers is extended, X is not extended.
Offers must acknowledge receipt of this amendment prior to the hour and date specified in the solicitation or as amended, by one of the following methods:
(a) By completing Items 8 and 15, and returning 1 copies of the amendment; (b) By acknowledging receipt of this amendment on each copy of the offer submitted; or (c) By separate letter or telegram which includes a reference to the solicitation and amendment numbers. FAILURE OF YOUR ACKNOWLEGMENT TO BE RECEIVED AT THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY RESULT IN REJECTION OF YOUR OFFER. If by virtue of this amendment you desire to change an offer already submitted, such change may be made by telegram or letter, provided each telegram or letter makes reference to the solicitation and this amendment, and is received prior to the opening hour and date specified.
12. ACCOUNTING AND APPROPRIATION DATA (If required)
13. THIS ITEM APPLIES ONLY TO MODIFICATIONS OF CONTRACTS/ORDERS,
IT MODIFIES THE CONTRACT/ORDER NO. AS DESCRIBED IN ITEM 14.
A. THIS CHANGE ORDER IS ISSUED PURSUANT TO: (Specify authority) THE CHANGES SET FORTH IN ITEM 14 ARE MADE IN THE CONTRACT ORDER NO. IN
B. THE ABOVE NUMBERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE ADMINISTRATIVE CHANGES (such as changes in paying office, appropriation date, etc.) SET FORTH IN ITEM 14, PURSUANT TO THE AUTHORITY OF FAR 43.103(b).
C. THIS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY OF:
D. OTHER (Specify type of modification and authority)
E. IMPORTANT: Contractor is not, is required to sign this document and return copies to the issuing office.
14. DESCRIPTION OF AMENDMENT/MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible.)
Amendment 4 to this solicitation is being issued to:
1. Suspend the soliciation until further notice.
2. Add a new point of contact (POC) Vic Veguilla, dhu3@cdc.gov.
3. Remove Jennifer Gartzke as the POC.
4. Evaluation of Phase I will continue as the samples are received; however, vendors will not be expected to submit results to the positive controls for B/Yamagata and B/Victoria. The progress into Phase II will be suspended until further notice.
5. All other terms and conditions remain unchanged.
Except as provided herein, all terms and conditions of the document referenced in Item 9A or 10A, as heretofore changed, remains unchanged and in full force and effect.
15A. NAME AND TITLE OF SIGNER (Type or print) 16A. NAME OF CONTRACTING OFFICER
Jennifer Gartzke
15B. CONTRACTOR/OFFEROR
(Signature of person authorized to sign)
15C. DATE SIGNED 16B. UNITED STATES OF AMERICA
BY ___________________________________________
(Signature of Contracting Officer)
16C. DATE SIGNED
ITEM 10A.
mailto:dhu3@cdc.gov
| 2025-04-15T10:10:15-0500 | |
| Jennifer Gartzke -S |
File details come from the government source that posted it. Updated .